Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03473197 · ClinicalTrials.gov registry record · Phase 1
A 6-Week Study to Evaluate the Photoallergic Potential of Diacerein 1% Ointment in Healthy Volunteers
A Phase 1 study, sponsored by Castle Creek Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 61
- Enrollment target
NCT03473197 is a Phase 1 study that has completed, run by Castle Creek Pharmaceuticals. The registered enrollment target is 61 participants.
The verdict
NCT03473197, a Phase 1 study, has completed, sponsored by Castle Creek Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 61 participants
- Enrollment target
Study Summary
A study in healthy male and female adult volunteers to determine the potential of diacerein 1% ointment to induce a photoallergic skin reaction using a controlled photopatch testing procedure.
Interventions
- DRUG Diacerein 1% ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2018-03-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03473197
The ClinicalTrials.gov registry entry for NCT03473197 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Castle Creek Pharmaceuticals, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diacerein 1% ointment is the first listed.
NCT03473197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03473197 about?
NCT03473197 is a clinical study titled "A 6-Week Study to Evaluate the Photoallergic Potential of Diacerein 1% Ointment in Healthy Volunteers". A study in healthy male and female adult volunteers to determine the potential of diacerein 1% ointment to induce a photoallergic skin reaction using a controlled photopatch testing procedure.
What is the current status of trial NCT03473197?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 61 participants. The study started on 2018-01-08. Estimated completion is 2018-03-09.
What interventions are being tested in trial NCT03473197?
The interventions under investigation include: Diacerein 1% ointment (DRUG).
Who is sponsoring clinical trial NCT03473197?
This trial is sponsored by Castle Creek Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.